# TACROLIMUS
> **ANDA213112** · Abbreviated New Drug Application (Generic) · Sponsor: CONCORD BIOTECH LTD · Approved 2020-11-10
## Drug
- **FDA Application Number:** ANDA213112
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TACROLIMUS
- **Generic name:** TACROLIMUS
- **Active ingredients:** TACROLIMUS
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CONCORD BIOTECH LTD
- **Manufacturer:** Stellon Biotech Inc.
- **First approval:** 2020-11-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213112)
---
*AI Analytics · CC0 1.0*